| Literature DB >> 22993354 |
Antonin Levy1, Avi Assouline, Sofia Rivera, Cyrus Chargari, Patricia Tai.
Abstract
Despite new aggressive therapeutical options for advanced malignant pleural mesothelioma (MPM), benefits to survival remain limited. Moreover, deleterious effects of high-dose chemotherapy and aggressive surgery are well-known. Outcomes of untreated patients are usually not reported, and whether a treatment can be delayed or avoided is still an open question. We discuss here two clinical cases and with conservative (palliative) management alone for advanced MPM [corrected].Entities:
Mesh:
Year: 2012 PMID: 22993354
Source DB: PubMed Journal: Anticancer Res ISSN: 0250-7005 Impact factor: 2.480